| RNA-based therapeutics: current progress and future prospects JC Burnett, JJ Rossi Chemistry & biology 19 (1), 60-71, 2012 | 880 | 2012 |
| Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity LS Weinberger, JC Burnett, JE Toettcher, AP Arkin, DV Schaffer Cell 122 (2), 169-182, 2005 | 609 | 2005 |
| Current progress of siRNA/shRNA therapeutics in clinical trials JC Burnett, JJ Rossi, K Tiemann Biotechnology journal 6 (9), 1130-1146, 2011 | 506 | 2011 |
| Nanoparticle-based delivery of RNAi therapeutics: progress and challenges J Zhou, KT Shum, JC Burnett, JJ Rossi Pharmaceuticals 6 (1), 85-107, 2013 | 192 | 2013 |
| Combinatorial latency reactivation for HIV-1 subtypes and variants JC Burnett, K Lim, A Calafi, JJ Rossi, DV Schaffer, AP Arkin Journal of virology 84 (12), 5958-5974, 2010 | 124 | 2010 |
| Gene and cell therapy: therapeutic mechanisms and strategies NS Templeton Crc Press, 2008 | 116 | 2008 |
| Current progress of RNA aptamer-based therapeutics J Zhou, M Bobbin, JC Burnett, JJ Rossi Frontiers in genetics 3, 234, 2012 | 115 | 2012 |
| Control of stochastic gene expression by host factors at the HIV promoter JC Burnett, K Miller-Jensen, PS Shah, AP Arkin, DV Schaffer PLoS Pathog 5 (1), e1000260, 2009 | 110 | 2009 |
| Potent and targeted activation of latent HIV-1 using the CRISPR/dCas9 activator complex SM Saayman, DC Lazar, TA Scott, JR Hart, M Takahashi, JC Burnett, ... Molecular therapy 24 (3), 488-498, 2016 | 104 | 2016 |
| HIV promoter integration site primarily modulates transcriptional burst size rather than frequency R Skupsky, JC Burnett, JE Foley, DV Schaffer, AP Arkin PLoS Comput Biol 6 (9), e1000952, 2010 | 99 | 2010 |
| Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells J Zhou, K Tiemann, P Chomchan, J Alluin, P Swiderski, J Burnett, ... Nucleic acids research 41 (7), 4266-4283, 2013 | 65 | 2013 |
| Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity J Zhou, S Satheesan, H Li, MS Weinberg, KV Morris, JC Burnett, JJ Rossi Chemistry & biology 22 (3), 379-390, 2015 | 61 | 2015 |
| RNA interference approaches for treatment of HIV-1 infection ML Bobbin, JC Burnett, JJ Rossi Genome medicine 7 (1), 1-16, 2015 | 57 | 2015 |
| HIV evades RNA interference directed at TAR by an indirect compensatory mechanism JN Leonard, PS Shah, JC Burnett, DV Schaffer Cell host & microbe 4 (5), 484-494, 2008 | 53 | 2008 |
| Molecular basis for improved gene silencing by Dicer substrate interfering RNA compared with other siRNA variants NM Snead, X Wu, A Li, Q Cui, K Sakurai, JC Burnett, JJ Rossi Nucleic acids research 41 (12), 6209-6221, 2013 | 51 | 2013 |
| Improvements and limitations of humanized mouse models for HIV research: NIH/NIAID “meet the experts” 2015 workshop summary R Akkina, A Allam, AB Balazs, JN Blankson, JC Burnett, S Casares, ... AIDS research and human retroviruses 32 (2), 109-119, 2016 | 49 | 2016 |
| Creating genetic resistance to HIV JC Burnett, JA Zaia, JJ Rossi Current opinion in immunology 24 (5), 625-632, 2012 | 47 | 2012 |
| High throughput sequencing analysis of RNA libraries reveals the influences of initial library and PCR methods on SELEX efficiency M Takahashi, X Wu, M Ho, P Chomchan, JJ Rossi, JC Burnett, J Zhou Scientific reports 6 (1), 1-14, 2016 | 45 | 2016 |
| Regulation of host gene expression by HIV-1 TAR microRNAs DL Ouellet, J Vigneault-Edwards, K Létourneau, LA Gobeil, I Plante, ... Retrovirology 10 (1), 1-15, 2013 | 44 | 2013 |
| The role of antisense long noncoding RNA in small RNA-triggered gene activation X Zhang, H Li, JC Burnett, JJ Rossi Rna 20 (12), 1916-1928, 2014 | 35 | 2014 |
David SchafferProfessor of Chemical and Biomolecular Engineering, Bioengineering, and Neuroscience, UC BerkeleyVerified email at berkeley.edu
